Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Snap Bio, Inc. logo — Unlocking Nature's Cures

Snap Bio, Inc.

Unlocking Nature's Cures

Founded 2017 United States San Diego, United States 2-10 employees Convertible Note Biotechnology

General Information

Company Name Snap Bio, Inc.
Founded Year 2017
Location United States San Diego, United States +1
Employees 2-10
Industries Biotechnology
Funding Stage Convertible Note
Social

Get notified when Snap Bio, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Snap Bio, Inc.

Snap Bio is a preclinical oncology company focused on delivering first-in-class treatments through a pioneering approach and platform. Our mission is to help patients suffering from challenging cancers where improved therapeutics are needed most. Snap Bio's unique approach starts with extremely potent inhibitors that have been evolved in Nature over millions of years. Rather than relying solely on conventional medicinal chemistry to modify these privileged scaffolds, Snap Bio employs its breakthrough synthetic biology platform to generate scaffold diversity and rapidly optimize selectivity and other properties important for clinical success. This approach has been validated through our lead program involving highly potent and selective inhibitors that disrupt multiple genetically-defined cancer growth and survival pathways. Snap Bio is advancing its promising liver cancer program, with a long-term goal of expanding to other cancer types in which its lead molecules already have shown strong efficacy.

No funding data available for Snap Bio, Inc. yet.

Get notified when Snap Bio, Inc. raises funding

Snap Bio, Inc. Alternatives & Competitors

Snap Bio, Inc. vs
Step Pharma
Step Pharma France

Developing selective inhibitors of CTPS1 for patients with cancer and auto-immune diseases

Series B
14 employees
Biotechnology, Pharmaceutical
Snap Bio, Inc. vs
Tradewind BioScience
Tradewind BioScience United States

Innovative therapeutics for the most aggressive cancers

Seed
5 employees
Biotechnology, Health Care
Snap Bio, Inc. vs
Zenith Epigenetics Ltd.
Zenith Epigenetics Ltd. Canada

Pioneering novel therapies through advanced epigenetic research to fight autoimmune diseases and can...

Unknown
11 employees
Biotechnology, Health Care

FAQ About Snap Bio, Inc.

Unlocking Nature's Cures
Snap Bio, Inc. was founded in 2017.
Snap Bio, Inc. is headquartered in San Diego, United States.
Snap Bio, Inc. operates in the following industries: Biotechnology.
Snap Bio, Inc. has approximately 2-10 employees.
Top alternatives and competitors to Snap Bio, Inc. include Step Pharma, Tradewind BioScience, Zenith Epigenetics Ltd., Akari Therapeutics, Plc, Stipple Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Snap Bio, Inc. and Step Pharma are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Snap Bio, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy